We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sensitive Test Developed for Sleeping Sickness

By LabMedica International staff writers
Posted on 05 Jun 2012
Proteins imitating typical parts of the sleeping sickness parasite can be used in more efficient diagnostic tests, without the need for culturing dangerous parasites. More...


In the regions where Trypanosoma brucei gambiense, the causative agent of sleeping sickness is found, medical workers for decades already use a rapid diagnostic test, to screen millions of people each year on the presence of antibodies in their blood.

A scientist at the Antwerp Institute of Tropical Medicine (Belgium) has developed a new and better test by trying to synthesize artificial targets. These 'mimotopes' mimic only a part of the original target protein, but still are sufficient to react with the patient's antibodies. The investigator produced mimotopes that are reliable and react with infected patients' serum. These mimotopes now can be the base for a new generation of rapid diagnostic tests for sleeping sickness.

In the original tests the antibodies are demonstrated by presenting them targets they will also recognize and attack on real trypanosomes such as the variable surface glycoprotein that cover the parasite as a mantle. When antibody and target react, the test is positive and is made visible by for instance a color change or a clotting. Today those targets are obtained from living parasites that are raised in laboratory animals, and are a constant danger for the laboratory technicians.

In an early stage, the disease is easy to treat, but once the brain is invaded, the treatment becomes more complex and physicians must use medicines with dangerous, even deadly, side effects. Therefore, it is important to detect the infection early. Patients become disoriented, their sleeping pattern disintegrates, and they get motor and mental problems. This inevitably leads to coma and death. According to the World Health Organization (WHO; Geneva, Switzerland) estimates, sleeping sickness claims 10,000 to 20,000 lives each year. In recent years, the number of cases has come down substantially, thanks to campaigns against the disease, so error margins that were acceptable in the old days, because the tests still saved so many lives, now become inadmissible.

Related Links:

Antwerp Institute of Tropical Medicine
World Health Organization



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Fusun Can (at left) is developing a test for detecting both resistance and virulence in Klebsiella pneumoniae (Photo courtesy of Koç University)

Rapid Diagnostic Breakthrough Simultaneously Detects Resistance and Virulence in Klebsiella Pneumoniae

Antibiotic resistance is a steadily escalating threat to global healthcare, making common infections harder to treat and increasing the risk of severe complications. One of the most concerning pathogens... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.